Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Bintrafusp alfa for advanced, unresectable cervical cancer	Bintrafusp alfa (M7824; GSK4045154)	Cervical cancer	Female Reproductive Cancer	2021	View \| Download
Bimekizumab for non-radiographic axial spondyloarthritis	Bimekizumab (UCB4940)	Axial spondyloarthritis	Rheumatology	2021	View \| Download
Bimekizumab for ankylosing spondylitis	Bimekizumab (UCB4940)	Ankylosing spondylitis	Musculoskeletal System	2021	View \| Download
Bimekizumab for active psoriatic arthritis	Bimekizumab (UCB4940)	Psoriatic arthritis	Dermatology , Rheumatology	2021	View \| Download
Bimatoprost slow-release for ocular hypertension or open-angle glaucoma	Bimatoprost SR Occular	Ocular hypertension	Ophthalmology	2021	View \| Download
Betula verrucosa for tree pollen allergy-induced moderate to severe rhinoconjunctivitis	Birch allergy vaccine (ALK tree AIT; Betula Verrucosa allergen extract)	Tree pollen allergy	Immunology	2021	View \| Download
Beremagene geperpavec for dystrophic epidermolysis bullosa	Bercolagene telserpavec (Beremagene geperpavec; KB103)	Dystrophic epidermolysis bullosa (DEB)	Dermatology	2021	View \| Download
Bentracimab for reversal of the antiplatelet activity of ticagrelor	Bentracimab (PB2452)	Bleeding , Uncontrolled bleeding	Haematology	2021	View \| Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Genetic Disorders , Oncology , Renal Cancer	2021	View \| Download
Belumosudil for graft versus host disease	Belumosudil (SLx-2119; KD025; KD-025)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download